Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    National Security
    Science & Regulatory
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Investor Forum
    BIO Asia-Taiwan

    July 15-19, 2026
    Taipei, Taiwan

    BIO Patient & Health Advocacy Summit
    BIO Patient Advocacy Changemakers Event

    October 22-23, 2026
    Washington, D.C

    BIO Asia-Taiwan
    BIO Europe

    November 9-11, 2026
    Cologne, Germany

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyNational SecurityScience & RegulatoryAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3199 results found
Expand All
Apply All
3199 results found

Brooks-LaSure makes history, lawmakers push back on TRIPS, H.R. 3
Share
Bio.News  •  May 26, 2021
We have a lot to report from Capitol Hill, including the new, history-making head of Centers for Medicare & Medicaid Services (CMS) and what a few lawmakers said about a TRIPS waiver and H.R. 3. Also, a new study tells us what consumers think about sustainable fashion. (744 words, 3 minutes, 43 seconds)
Read More

G20 leaders and biopharmas pledge to share vaccines
Share
Bio.News  •  May 25, 2021
G20 leaders pledged to share vaccines and USDA published some ideas on climate-smart ag and forestry—and many of these ideas are aligned with things BIO’s proposed. (896 words, 4 minutes, 28 seconds)
Read More

Why we can and must SHARE vaccines globally
Share
Bio.News  •  May 24, 2021
Starting the week before Memorial Day with a new podcast on why we must SHARE vaccines globally, plus a new op-ed from Dr. Michelle McMurry-Heath on how we can “science our way out” of the climate crisis—and a busy Monday on the Hill. (832 words, 4 minutes, 9 seconds)
Read More

BIO Letter Supporting SAF Tax Credit
Share
Letters, Testimony & Comments  •  May 21, 2021
BIO applauds your leadership in the development and introduction of the Sustainable Skies Act, a blender’s tax credit (BTC) to incentivize the production and use of sustainable aviation fuel (SAF). To meet the challenge of climate change, it is crucial to lead with science and U.S. innovation. Because of biotech innovations, the production of biofuels is becoming more efficient and environmentally sustainable. These technological breakthroughs have led to the development of SAF derived from renewable biomass and waste byproducts, which can reduce lifecycle greenhouse gas emissions by up to 80 percent compared to conventional jet fuel. By supporting policies that advance pioneering technology breakthroughs we can return our Nation and the world to health and prosperity. BIO is committed to working with Congress to address the climate crisis and advance legislation, such as the Sustainable Skies Act that catalyzes resilient and sustainable biobased economies.
Read More

Lawmakers propose SAF tax credit
Share
Bio.News  •  May 21, 2021
Ending the week with news from Congress on a proposed tax credit for sustainable aviation fuel, Biden’s top scientist, and closing patent gaps—plus, how you can travel to five continents in two days, no quarantine required. (622 words, 3 minutes, 6 seconds)
Read More

BIO and Members Join Letter Supporting SAF Tax Credit
Share
Agriculture & Environment, Sustainable Fuels  •  Letters, Testimony & Comments  •  May 20, 2021
As fuel producers and organizations committed to the development of a robust sustainable aviation fuel (SAF) industry to help decarbonize the aviation industry with drop-in, low-carbon replacements for conventional aviation fuels, we write to express our strong support for the Sustainable Skies Act. The legislation will send a needed long-term investment signal to help scale the SAF industry, will address existing policy disincentives currently limiting SAF deployment and investment, and, most importantly, will meaningfully reduce aviation’s climate and air quality impacts while driving economic growth. We thank Representatives Schneider, Kildee, and Brownley and your staff for the work that went into the development of the SAF BTC, and we stand ready to assist you in making this impactful legislation into law.
Read More

BIO Joins Coalition Letter Supporting SAF Tax Credit
Share
Agriculture & Environment, Sustainable Fuels  •  Letters, Testimony & Comments  •  May 20, 2021
As organizations committed to addressing climate change, we are writing to express our strong support for the Sustainable Skies Act. This bill will help increase the production and uptake of sustainable aviation fuel (SAF) and reduce the aviation sector’s reliance on petroleum-based jet fuel, ensuring real reductions in aviation emissions. We applaud you for introducing this bill and stand ready to assist in whatever way we can to ensure the measure is approved by both chambers of Congress.
Read More

5 AAPI scientists and innovators to know
Share
Bio.News  •  May 20, 2021
Today, President Biden will sign important legislation addressing anti-Asian hate crimes. We applaud the law’s passage—and the important contributions of the AAPI community to innovation. Also, two of the best science communicators we know tells us more about the “bio-revolution,” and we recap yesterday's HHS appropriations hearing. (1078 words, 5 minutes, 23 seconds)
Read More

Biopharma groups pledge vaccine equity
Share
Bio.News  •  May 19, 2021
Everyone’s talking about COVID vaccine equity—but what should we REALLY do to make it happen? We joined a commitment outlining five concrete steps. Meanwhile, we tell you what you need to watch in D.C. today and how you can support farmers and the planet. (762 words, 3 minutes, 48 seconds)
Read More

BIO Cheers Biden Announcement to Share 20 Million Doses of Vaccines with Developing Nations
Share
Vaccines  •  Press Release  •  May 18, 2021
"The White House’s decision to send Covid-19 vaccines to countries in need is an important step to ensuring people around the globe have access to lifesaving shots and ending this global pandemic. “As part of BIO’s recently-proposed Global “SHARE” program, we’ve made clear the urgent need to strengthen and support healthcare systems in low-and middle-income countries in addressing COVID. The president’s decision to relinquish millions of doses is an important part of achieving this goal. “Going forward, we hope the administration will continue to look towards equity for global vaccine availability and distribution. Another great step would be to eliminate the financial contingencies which have been put in place which currently act as a barrier to COVAX. “BIO member companies have worked around the clock to find the scientific solutions we need to end this pandemic. We look forward to working with the White House to ensure people in every corner of the world have access to those solutions without damaging the premise of intellectual property on which this nation was built.”
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 189
  • 190
  • 191
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO